Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2665–2688 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Wound Healing
Interventions: Procellera™ Wound Dressing with V.A.C.® Therapy, V.A.C.® Therapy; Device
Lead sponsor: Vomaris Innovations; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Liver Metastases
Interventions: [18-F]- FDG - PET, Tumor ablation (TA), PET/CT Scan; Diagnostic Test · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Peripheral Arterial Disease
Interventions: Shockwave Intravenous lithotripsy with a Supera stent; Device
Lead sponsor: Cardiovascular Institute of the South Clinical Research Corporation; Other
Eligibility: 18 Years and older
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Houma, Louisiana

Conditions: Psoriasis, Plaque Psoriasis
Interventions: MK-0873 2% Cream, MK-0873 vehicle (placebo) Cream, Calcitriol Cream; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Fort Myers, Florida • Miramar, Florida

Conditions: Atrial Fibrillation, Postoperative
Interventions: The intervention includes Amiodarone-Infused CardiaMend patches (70mg, 150mg and 300mg); Combination Product
Lead sponsor: Helios Cardio Inc.; Industry
Eligibility: 20 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Tobacco Smoking
Interventions: Cognitive-Behavioral Smoking Cessation, Heart Rate Variability Biofeedback (HRVB), Transdermal Nicotine patch; Behavioral · Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 21 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Tobacco Dependence
Interventions: Tobacco/Physical Activity Intervention, Diet plus BP/CHOL Intervention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 19 Years and older
Enrollment: 299 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Nome, Alaska • Stanford, California

Conditions: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma
Interventions: Cemiplimab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 9
States / cities: Phoenix, Arizona • San Diego, California • Delray Beach, Florida + 6 more

Conditions: Parkinson Disease, Parkinson Disease Dementia
Interventions: Rivastigmine transdermal patch; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetic Foot Ulcer (DFU), Amnio-Maxx
Interventions: Amnio-Maxx® Dual Layer Amnion Patch, Standard of Care (Investigator Choice); Biological · Other
Lead sponsor: Royal Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Burbank, California • Miami, Florida • Stone Mountain, Georgia + 5 more

Conditions: Giant Cell Tumor of Bone
Interventions: Zoledronic Acid; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 14
States / cities: Los Angeles, California • Indianapolis, Indiana • Iowa City, Iowa + 9 more

Conditions: Heart Failure, Heart Murmurs
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: Up to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Prostate Cancer
Interventions: [18F]-DCFPyl Ligand; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Solid Tumor
Interventions: Endoscopic ultrasound guided fine needle biopsy; Procedure
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 18 Years to 80 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Biopsy, Fine-needle, Pancreatic Neoplasm
Interventions: Rapid on-site evaluation (ROSE), Histologic evaluation; Diagnostic Test
Lead sponsor: Azienda Ospedaliera Universitaria Integrata Verona; Other
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite
Interventions: CCH-aaes, Compression, Cold Packs, Arnica Gel, INhance®, PDL; Drug · Other
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: Scottsdale, Arizona • Sacramento, California • San Diego, California + 5 more

Conditions: Deglutition Disorders
Interventions: Tele-EaT Sensors, Conventional Sensors; Device
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Coronary Atherosclerosis of Native Coronary Artery, Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary Artery
Interventions: Tryton Side Branch Stent with main branch DES, POBA; Device
Lead sponsor: Tryton Medical, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Gastroenterology, Lesions
Interventions: Endoscopic ultrasound- (EUS) guided tissue sampling; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Coronary Artery Disease
Interventions: Intracoronary ECG; Procedure
Lead sponsor: University National Heart Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pigmented Lesions
Interventions: BroadBand Light; Device
Lead sponsor: Sciton; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Los Gatos, California

Conditions: Prostate Cancer
Interventions: Exablate Prostate Treatment; Device
Lead sponsor: InSightec; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 5
States / cities: Stanford, California • Delray Beach, Florida • Boston, Massachusetts + 2 more

Conditions: Vision, Low, Blindness
Interventions: Interaction with Mock COVID-19 Rapid Antigen Test and Reference Surfaces, Biomechanical Measurements, Psychophysical Tasks; Diagnostic Test · Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 12 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Cytokine Release Syndrome, Neoplasms, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Multiple Myeloma, Lymphoma Mantle-cell, Immunotherapy, Cell and Tissue-Based Therapy, Cytokines, Monitoring Physiologic, Immune Monitoring, Wearable Electronic Devices, Thermometry, Body Temperature, Antibodies Bispecific, Receptors Chimeric Antigen
Interventions: TempTraq, VitalTraq; Device
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Shockwave: Disruption for A Better Fit

A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects

Heart Rate Variability Biofeedback for Smoking Cessation

Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients

Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand

Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.

EUS-FNB With ROSE Vs. EUS-FNB Without ROSE

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

Wearable Monitoring Systems for Swallowing Function and Disorders

Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries

Evaluation of Diagnostic Yield of EUS-Guided Tissue Sampling

FFR vs. icECG in Coronary Bifurcations

Pilot Evaluation of Smart vs HERO Broadband Light Treatment for Pigmented Skin Lesions

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Validation of Texture Changing Coatings for Use in At-Home Rapid Tests

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event